Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 14,940 shares at $21.47 ($320K) on 2017-07-13, disclosed to the SEC on 2017-07-17.
Open-market sale of $320k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.47 | 8,974 | $193K | 60.2% |
| 2 | $21.39 | 5,666 | $121K | 37.8% |
| 3 | $21.38 | 300 | $6K | 2.0% |
| Total | $21.44 avg | 14,940 | $320K | 100% |